Merck's anti-clotting drug flops in key trial

Sunday, November 13, 2011 - 08:30 in Health & Medicine

ORLANDO, Fla. (AP) -- A blood thinner being developed by Merck has flopped in a major study aimed at preventing heart attacks, strokes and other problems in people who had suffered a heart attack or severe chest pain from clogged arteries....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net